Asia · Regional markets · Korea Economic Daily

Samsung Biologics wins nearly full backing in PolyPeptide tender offer

Published by Korea Economic Daily · South Korea 15 h ago

Samsung Biologics Co. said on Monday its tender offer for PolyPeptide Group drew 97.98% final acceptances, clearing both the minimum threshold for the 1.46 bil ...

Read the full article on Korea Economic Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.kedglobal.com)

Also worth reading

CNBC-TV18

Explained - Why Dow Jones, Nasdaq fell as much as 750 points from the highs on Monday

Mint

Samsung Biologics wins nearly full backing in PolyPeptide tender offer

Share

Also worth reading

Explained - Why Dow Jones, Nasdaq fell as much as 750 points from the highs on Monday

China Boosts Use of Stock Support Tools to Stabilize Market

STI’s total returns slide 5.2% in October; tech index plunges 17.3%

S&P 500 ends down; Apple dips ahead of quarterly report

IPO fundraising rises 30% to record ₹84,400 crore in H1FY27: Report

Goldman restricts traders and bankers from using some AI tools — Bloomberg